- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05677061
Clinical Evaluation on HA Coated Dynamic Hip Screws for Trochanteric Femoral Fractures
February 8, 2023 updated by: University of Aarhus
Evaluated whether HA coated dynamic hip screws can improve fixation of the screw in trochanteric femoral fractures
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Randomised study to determine the effect of HA coating on the stability of dynamic Hip screws used to stabilize femoral neck fractures.
Stability of the screw will be determined by RSA measurements.
Additionally the fracture stability will be evaluated by RSA measurements.
Study Type
Interventional
Enrollment (Actual)
37
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with stable intertrochanteric femoral fractures (Evans I, II, IV)
- able to speak Danish
- able to complete the postoperative controls
- written consent
Exclusion Criteria:
- unable to follow standard hip fracture regime
- were breastfeeding
- pregnant
- terminal disease
- in need of open fracture reduction
- in need of DHS plate with an angle different from 135 degrees
- insertion of fewer than 3 tantalum beads in the femoral head (for RSA)
- TAD >20mm in two dimensions in the first postoperative x-ray
- fracture displacement >20mm in two dimensions in the first postoperative x-ray
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: HA-coated
Hydroxyapatite coating on Screw thread of DHS
|
During surgery for pertrochanteric hip fracture a lag screw with hydroxyapatite coating on the screw thread was used to fix the fracture
|
ACTIVE_COMPARATOR: NON-coated
No coating on Screw thread of DHS
|
During surgery for pertrochanteric hip fracture a lag screw with no coating on the screw thread was used to fix the fracture
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lag Screw migration measured as y-translation (mm)
Time Frame: 6 months PO
|
Lag screw migration measured as y-translation (mm) with respect to the femoral head/neck fracture segment using marker-based radiostereometry (ModelBased RSA vs 4.2 or newer) until 6 months follow-up
|
6 months PO
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lag screw migration measured as translations in mm
Time Frame: 6 months PO
|
Lag screw migration measured as translations in mm along the three orthogonal axes (x and z) and rotations in degrees about the three orthogonal axes (x, y and z) in addition to the summed translations (total translation) and summed rotations (total rotation) with respect to the femoral head/neck fracture segment using marker-based radiostereometry (ModelBased RSA vs 4.2 or newer) until 6 months follow-up
|
6 months PO
|
Lag screw migration measured as rotations in degrees
Time Frame: 6 months PO
|
Lag screw migration measured as rotations in degrees about the three orthogonal axes (x, y and z) in addition to the summed summed rotations (total rotation) with respect to the femoral head/neck fracture segment using marker-based radiostereometry (ModelBased RSA vs 4.2 or newer) until 6 months follow-up
|
6 months PO
|
Radiological measurements
Time Frame: 6 months
|
TAD AP+LAT, fracture reposition AP+LAT (mm)
|
6 months
|
Clinical outcomes - HHS
Time Frame: 6 months PO
|
Change in Harris Hip Score (HHS) measured as a scale from 0 (worst) to 100 (best) from pre-operative til 6 months postoperative
|
6 months PO
|
Clinical outcomes - NMS
Time Frame: Preoperative
|
New Mobility Score measured on a scale from 0 (no mobility function) to 9 (full independent mobility function) preoperative
|
Preoperative
|
Clinical outcomes - Leg Lengths difference
Time Frame: 6 months
|
Leg Length difference in cm at 6 months follow-up indicate fracture impaction
|
6 months
|
Clinical outcomes - TUG test
Time Frame: 6 months
|
Timed Up and Go Test (TUG) at 6 months follow-up (a score less than 20 seconds indicate mobility independence)
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 1, 2008
Primary Completion (ACTUAL)
August 1, 2013
Study Completion (ACTUAL)
February 1, 2023
Study Registration Dates
First Submitted
December 7, 2022
First Submitted That Met QC Criteria
January 5, 2023
First Posted (ACTUAL)
January 10, 2023
Study Record Updates
Last Update Posted (ESTIMATE)
February 9, 2023
Last Update Submitted That Met QC Criteria
February 8, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-KF-298036
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Not possible due til GDPR restrictions
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intertrochanteric Fractures
-
Peking University Third HospitalBeijing Yanqing HospitalRecruitingFemoral Intertrochanteric FracturesChina
-
Tel-Aviv Sourasky Medical CenterUnknownIntertrochanteric Fractures of the HipIsrael
-
Peifu TangRecruitingIntertrochanteric FractureChina
-
Uppsala UniversityCompleted
-
Stryker Trauma GmbHGlobal Research SolutionsCompletedFemoral Neck Fractures | Intertrochanteric FractureUnited States, United Kingdom, Canada, Denmark, Germany, Australia, China, Colombia, Japan, Netherlands, Norway, South Africa
-
Stryker Trauma GmbHGlobal Research Solutions; Stryker OsteosynthesisCompletedFemoral Neck Fractures | Intertrochanteric FractureSweden, Denmark, Canada
-
King Chulalongkorn Memorial HospitalUnknownUnstable Intertrochanteric FractureThailand
-
Florida Orthopaedic InstituteUnknownHip Fracture | Intertrochanteric FractureUnited States
-
Kahramanmaras Sutcu Imam UniversityCompletedFemur Intertrochanteric FracturesTurkey
Clinical Trials on Dynamic Hip Screw with HA-coating (Hiploc)
-
Zimmer BiometHvidovre University Hospital; Biomet U.K. Ltd.Withdrawn
-
Sohag UniversityRecruiting
-
University Hospital, ToursCompletedOther Reconstructive SurgeryFrance
-
RWTH Aachen UniversityCompleted
-
Issa, Abdulhamid Sayed, M.D.Completed
-
Kushtrim GrezdaUniversity Clinical Centre of KosovaCompleted
-
Ibn Jazzar HospitalCompletedProximal Femur FracturesTunisia
-
University of LeedsCitieffe S.r.lUnknownUnilateral Unstable HipUnited Kingdom
-
Security Forces HospitalCompletedAvascular Necrosis | Femoral Neck FracturesSaudi Arabia
-
Stryker Trauma GmbHGlobal Research Solutions; Stryker OsteosynthesisCompletedFemoral Neck Fractures | Intertrochanteric FractureSweden, Denmark, Canada